Pfizer Inc

NYSE: PFE
$28.84
-$0.09 (-0.3%)
Closing Price on October 22, 2024

PFE Articles

ThinkstockEven the best firms on Wall Street sometimes lose their analysts, and when that happens they are forced to suspend their coverage on stocks until they can replace the talent. Oppenheimer...
ThinkstockAs the pharmaceuticals industry looks toward restructuring and separation of undervalued assets, Jefferies analysts have prepared a highly proprietary sum of the parts analysis for their...
Jon OggThe bull market appears to still be alive and well for equities, but the risk of rising interest rates is plaguing bonds and investments tied to big dividends. What equity investors also need...
U.S. equity markets opened barely higher this morning following a report that mortgage loan applications had fallen by 9.8% from the previous week, on top of a 7% decline for the prior period. In...
ThinkstockOne of the downsides to a market that seems to go up every day is knowing what stocks to own or sell as the market chugs higher. One strategy for investors to consider is keep a weighting...
Wikimedia CommonsYesterday’s announcement by Pfizer Inc. (NYSE: PFE) that it would begin selling its blockbuster Viagra drug online directly to patients is a genuinely ground-breaking deal. The big...
ThinkstockNow that Pfizer Inc. (NYSE: PFE) has started to sell Viagra online at Viagra.com, can Cialis.com and Levitra.com be far behind? These two other drugs face the same black market trouble...
ThinkstockThe U.S. government accuses China of stealing military secrets. (Reuters) Microsoft Corp. (NASDAQ: MSFT) plans to upgrade Windows 8 to boost sales. (Reuters) New York state will file...
Wikimedia CommonsMen, or their significant others, will be able to buy Pfizer Inc.’s (NYSE: PFE) erectile dysfunction drug Viagra online soon. Maybe the big pharmaceutical company figures it is...
ThinkstockIron Man’s Record Weekend Walt Disney Co.’s (NYSE: DIS) “Iron Man 3” could save the summer box office yield all by itself. Like several serial movie franchises, each installment...
Jon OggBiotech stocks come and go as far as the flavor of the day for investors. While many of these companies are risky, and while many are too risky for many investors, what investors need to know...
ThinkstockDrug giant Pfizer Inc. (NYSE: PFE) this morning reported adjusted earnings and revenues that missed analysts estimates, and the stock is down more than 3%. Last week competitor Amgen Inc....
This week should mark the climax of first quarter corporate earnings season. It will be a full week for the earnings calendar, along with key economic events and some corporate annual meetings to...
While the current stock market rally has been impressive since the lows last November, many investors, analysts and equity strategists are casting a wary eye at the looming May 1 date. In a new...
courtesy of Facebook Inc.Martha Stewart Omnimedia Inc. (NYSE: MSO) is unable to get a court to dismiss charges by Macy’s Inc. (NYSE: M) that it has exclusive rights to some of her products....